Alexion's Ultomiris Hits Mark in Phase III for Myasthenia Gravis

Retrieved on: 2021-07-16 16:07:30

Tags for this article:

Organ systems

Medical specialties

Branches of biology

Acquired hemolytic anemia

Rare diseases

Blood disorders

Alexion Pharmaceuticals

AstraZeneca

Eculizumab

Atypical hemolytic uremic syndrome

Myasthenia gravis

Thrombotic microangiopathy

Boston

Click the tags to see associated articles and topics

Alexion's Ultomiris Hits Mark in Phase III for Myasthenia Gravis. View article details on hiswai: https://www.biospace.com/article/alexion-s-ultomiris-hits-mark-in-phase-iii-for-myasthenia-gravis/

Excerpt

Boston-based Alexion Pharmaceuticals announced positive topline data from its Phase III trial of Ultomiris (ravulizumab-cwvz) in adults with generalized ...

Article found on: www.biospace.com

View Original Article